DK58292D0 - Som mellemprodukter anvendelige 4(5)-imidazolderivater - Google Patents

Som mellemprodukter anvendelige 4(5)-imidazolderivater

Info

Publication number: DK58292D0
Authority: DK; Denmark
Prior art keywords: och3; ch2ch3; hal; compounds; applicable
Prior art date: 1984-11-23

Application number

DK92582A

Other languages

English (en)

Other versions

DK58292A (da

Inventor

Arto Johannes Karjalainen

Raimo Einari Virtanen

Arje Leena Karjalainen

Kauko Oiva Antero Kurkela

Original Assignee

Orion Yhtymae Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-11-23

Filing date

1992-05-04

Publication date

1992-05-04

1992-05-04 Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy

1992-05-04 Publication of DK58292A publication Critical patent/DK58292A/da

1992-05-04 Publication of DK58292D0 publication Critical patent/DK58292D0/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Diaphragms For Electromechanical Transducers (AREA)
Dental Preparations (AREA)
Golf Clubs (AREA)
Lubricants (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Epoxy Resins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK92582A 1984-11-23 1992-05-04 Som mellemprodukter anvendelige 4(5)-imidazolderivater DK58292D0 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB08429578A GB2167408B (en)	1984-11-23	1984-11-23	Substituted imidazole derivatives and their preparation and use

Publications (2)

Publication Number	Publication Date
DK58292A DK58292A (da)	1992-05-04
DK58292D0 true DK58292D0 (da)	1992-05-04

Family

ID=10570140

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK540485A DK164903C (da)	1984-11-23	1985-11-22	Substituerede imidazolderivater og fremgangsmaader til fremstilling deraf
DK92582A DK58292D0 (da)	1984-11-23	1992-05-04	Som mellemprodukter anvendelige 4(5)-imidazolderivater

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK540485A DK164903C (da)	1984-11-23	1985-11-22	Substituerede imidazolderivater og fremgangsmaader til fremstilling deraf

Country Status (26)

Country	Link
US (1)	US4689339A (da)
EP (2)	EP0310745B1 (da)
JP (1)	JPH064597B2 (da)
KR (1)	KR930004673B1 (da)
AT (2)	ATE85050T1 (da)
AU (2)	AU586839B2 (da)
BG (1)	BG60762B2 (da)
CA (1)	CA1268770C (da)
DD (1)	DD258230A1 (da)
DE (2)	DE3574252D1 (da)
DK (2)	DK164903C (da)
ES (2)	ES8704462A1 (da)
FI (1)	FI80264C (da)
GB (1)	GB2167408B (da)
GR (1)	GR852817B (da)
HK (1)	HK3592A (da)
HU (1)	HU195189B (da)
IE (1)	IE58165B1 (da)
IL (1)	IL77111A (da)
NO (1)	NO166585C (da)
NZ (1)	NZ214258A (da)
PH (1)	PH22016A (da)
PT (1)	PT81542B (da)
SG (1)	SG106891G (da)
SU (1)	SU1424736A3 (da)
ZA (1)	ZA858942B (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0252162A4 (en) *	1986-01-28	1988-07-29	Mitsui Petrochemical Ind	PROCESS FOR THE PREPARATION OF NON-SUBSTITUTED 2-IMIDAZOLES.
FI81092C (fi) *	1986-05-15	1990-09-10	Farmos Oy	Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.
FI862039A0 (fi) *	1986-05-15	1986-05-15	Farmos Oy	Nytt foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat.
JP2576493B2 (ja) *	1987-03-20	1997-01-29	アイシン精機株式会社	原稿読取り装置に用いられる原稿トレ−
FR2621327B1 (fr) *	1987-10-06	1990-01-05	Commissariat Energie Atomique	Procede de production et d'extraction de polysaccharides a partir d'une culture de porphyridium cruentum et dispositif pour la mise en oeuvre du procede
GB2225782A (en) *	1988-12-09	1990-06-13	Farmos Group Limited	Imidazole derivatives useful for treatment of diabetes
GB8903437D0 (en) *	1989-02-15	1989-04-05	Erba Carlo Spa	Imidazolyl derivatives of 3,4-dihydro-2h-1-benzothiopyran
CA1321751C (en) *	1989-02-21	1993-08-31	Eugene C. Crichlow	Mechanism mediating ruminal stasis in ruminal lactic acidosis
DK344489D0 (da) *	1989-07-12	1989-07-12	Novo Nordisk As	Substituerede 2-imidazoliner og fremstilling og anvendelse deraf
GB2244431A (en) *	1990-05-31	1991-12-04	Farmos Oy	Treatment of age related memory impairment and other cognitive disorders
GB2256135B (en)	1991-05-31	1995-01-18	Orion Yhtymae Oy	Transdermal administration of 4-substituted imidazoles
US5541211A (en) *	1991-06-18	1996-07-30	Orion-Yhtyma Oy	Administration of atipamezole to elicit a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic transmission
DK0612244T3 (da) *	1991-11-05	2002-01-14	Smithkline Beecham Corp	Endothelinreceptorantagonister
GB9127050D0 (en) *	1991-12-20	1992-02-19	Orion Yhtymae Oy	Substituted imidazole derivatives and their preparation and use
GB9127430D0 (en) *	1991-12-27	1992-02-19	Scras	Benzofuranylimidazole derivatives
GB9312669D0 (en) *	1993-06-18	1993-08-04	Orion Yhtymae Oy	New opticla isomers
GB9425211D0 (en) *	1994-12-14	1995-02-15	Ucb Sa	Substituted 1H-imidazoles
FR2733983B1 (fr) *	1995-05-10	1997-08-01	Pf Medicament	Procede de preparation d'un derive d'acide benzofurane carboxylque optiquement pur et son utilisation pour preparer l'efaroxan
GB9520150D0 (en)	1995-10-03	1995-12-06	Orion Yhtymae Oy	New imidazole derivatives
FR2754709B1 (fr)	1996-10-23	1999-03-05	Sanofi Sa	Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
AU8031698A (en) *	1997-06-05	1998-12-21	Venantius Limited	Indane compounds and their pharmaceutical use
WO1999051593A1 (en) *	1998-04-02	1999-10-14	Ortho-Mcneil Pharmaceutical, Inc.	4-thionaphthyl-1h-imidazoles with alpha-2-adrenergic activity
FR2784989B1 (fr) *	1998-09-10	2002-09-27	Fabre Pierre Sante	Derive d'ester d'acide 2-ethyl-2,3-dihydrobenzofurane- carboxylique, procede de preparation et utilisation pour la preparation de derives de l'efaroxan
AU3033100A (en) *	1999-01-18	2000-08-01	Boehringer Ingelheim International Gmbh	Substituted imidazoles, their preparation and use
US6388090B2 (en) *	2000-01-14	2002-05-14	Orion Corporation	Imidazole derivatives
US6593324B2 (en)	2000-03-01	2003-07-15	Orion Corporation	Dervatives of quinoline as alpha-2 antagonists
CA2408290A1 (en) *	2000-05-08	2001-11-15	Orion Corporation	New polycyclic indanylimidazoles with alpha2 adrenergic activity
US6503894B1 (en)	2000-08-30	2003-01-07	Unimed Pharmaceuticals, Inc.	Pharmaceutical composition and method for treating hypogonadism
US6543389B2 (en)	2001-06-26	2003-04-08	Pfizer Inc.	Insecticidal pet collar
EP1490361B1 (en)	2002-04-03	2007-10-03	Orion Corporation	Polycyclic compounds as potent alpha2-adrenoceptor antagonists
US8188126B2 (en)	2002-05-16	2012-05-29	Pierre Fabre Medicament	Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
FI116292B (fi) *	2003-01-08	2005-10-31	Juvantia Pharma Ltd Oy	Menetelmä substituoitujen imidatsolijohdannaisten valmistamiseksi ja menetelmässä käytettäviä välituotteita
ATE411799T1 (de) *	2003-11-04	2008-11-15	Intervet Int Bv	Ectoparasitische formulierungen von spinosyns und azol-pestiziden
FI20050657A0 (fi) *	2005-06-17	2005-06-17	Orion Corp	Atipametsolin kiteytysmenetelmä
NZ567056A (en)	2005-10-12	2012-02-24	Unimed Pharmaceuticals Llc	Improved testosterone gel and method of use
US7592461B2 (en)	2005-12-21	2009-09-22	Bristol-Myers Squibb Company	Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
ATE459251T1 (de) *	2006-08-08	2010-03-15	Intervet Int Bv	Zusammensetzung für verstärkte antiparasitische wirksamkeit
TWI457122B (zh)	2007-07-20	2014-10-21	Orion Corp	作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3－二氫苯並[1,4]戴奧辛－2－基甲基衍生物
CL2008003553A1 (es) *	2007-12-05	2009-11-27	Grindeks Jsc	Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
MX2016005996A (es)	2013-11-05	2016-08-11	3M Innovative Properties Co	Formulaciones de inyeccion con base en aceite de ajonjoli.
TWI704145B (zh)	2015-06-05	2020-09-11	芬蘭商奧利安公司	新醫藥化合物
WO2017079734A1 (en) *	2015-11-05	2017-05-11	University Of Louisville Research Foundation, Inc.	Local and regional anesthesia and analgesia
JP2019519582A (ja)	2016-06-29	2019-07-11	オリオンコーポレーション	ベンゾジオキサン誘導体およびその医薬用途
WO2020126536A1 (en)	2018-12-21	2020-06-25	Societe Des Produits Nestle S.A.	Nutritional composition for inducing a feeling of satiety, a better sleep and/or limiting nocturnal awaking in infants or young children
CN111978254A (zh) *	2019-05-22	2020-11-24	南京康德祥医药科技有限公司	一种阿替美唑盐酸盐的制备工艺
CN111925330A (zh) *	2020-09-07	2020-11-13	上海阿达玛斯试剂有限公司	一种阿替美唑的制备方法
LU103072B1 (en)	2023-02-15	2024-08-19	Univ Ljubljani	N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-lH-IMIDAZOLE-l-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES
WO2024160908A1 (en)	2023-02-01	2024-08-08	Univerza V Ljubljani	N,n-dialkyl-4-(2-ethylindan-2-yl)-1h-imidazole-1-carboxamides and related compounds for treatment of neurodegenerative diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2933962A1 (de) *	1979-08-22	1981-03-26	Hoechst Ag, 65929 Frankfurt	Verfahren zur herstellung von 4,5-dichlor-imidazolen.
US4342775A (en) *	1980-03-04	1982-08-03	Farmitalia Carlo Erba S.P.A.	3-(1-Imidazolyl)-derivatives of 2,3-dihydro-4H-1-benzopyran
US4302469A (en) *	1980-09-10	1981-11-24	Syntex (U.S.A.) Inc.	2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
ZW13782A1 (en) *	1981-07-28	1982-10-06	Reckitt & Colmann Prod Ltd	Imidazoline derivatives
ES523609A0 (es) *	1982-07-05	1985-03-01	Erba Farmitalia	Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.
FR2539415B1 (fr) *	1983-01-14	1985-09-13	Adir	Derives de la d-2 imidazoline, leur preparation et leur application en therapeutique
FR2542738A1 (fr) *	1983-03-18	1984-09-21	Synthelabo	Indanyl-2 d2-imidazoline, procede pour la preparer, et compositions pharmaceutiques qui la contiennent

1984
- 1984-11-23 GB GB08429578A patent/GB2167408B/en not_active Expired
1985
- 1985-11-05 FI FI854335A patent/FI80264C/fi not_active IP Right Cessation
- 1985-11-18 CA CA 495608 patent/CA1268770C/xx not_active Expired - Lifetime
- 1985-11-20 IL IL77111A patent/IL77111A/xx not_active IP Right Cessation
- 1985-11-20 DD DD85283044A patent/DD258230A1/de not_active IP Right Cessation
- 1985-11-20 AU AU50083/85A patent/AU586839B2/en not_active Expired
- 1985-11-20 NZ NZ214258A patent/NZ214258A/xx unknown
- 1985-11-21 IE IE292985A patent/IE58165B1/en not_active IP Right Cessation
- 1985-11-21 DE DE8585308491T patent/DE3574252D1/de not_active Expired
- 1985-11-21 EP EP88106210A patent/EP0310745B1/en not_active Expired - Lifetime
- 1985-11-21 ZA ZA858942A patent/ZA858942B/xx unknown
- 1985-11-21 KR KR1019850008704A patent/KR930004673B1/ko not_active IP Right Cessation
- 1985-11-21 AT AT88106210T patent/ATE85050T1/de not_active IP Right Cessation
- 1985-11-21 GR GR852817A patent/GR852817B/el unknown
- 1985-11-21 US US06/800,192 patent/US4689339A/en not_active Expired - Lifetime
- 1985-11-21 AT AT85308491T patent/ATE47997T1/de not_active IP Right Cessation
- 1985-11-21 EP EP85308491A patent/EP0183492B1/en not_active Expired
- 1985-11-21 PH PH33077A patent/PH22016A/en unknown
- 1985-11-21 DE DE8888106210T patent/DE3587045T2/de not_active Expired - Fee Related
- 1985-11-22 HU HU854471A patent/HU195189B/hu unknown
- 1985-11-22 JP JP60263586A patent/JPH064597B2/ja not_active Expired - Lifetime
- 1985-11-22 DK DK540485A patent/DK164903C/da not_active IP Right Cessation
- 1985-11-22 NO NO854671A patent/NO166585C/no unknown
- 1985-11-22 PT PT81542A patent/PT81542B/pt unknown
- 1985-11-22 ES ES549178A patent/ES8704462A1/es not_active Expired
- 1985-11-22 SU SU853979907A patent/SU1424736A3/ru active
1986
- 1986-12-29 ES ES557268A patent/ES8801248A1/es not_active Expired
1989
- 1989-04-21 AU AU33329/89A patent/AU3332989A/en not_active Abandoned
1991
- 1991-12-17 SG SG1068/91A patent/SG106891G/en unknown
1992
- 1992-01-09 HK HK35/92A patent/HK3592A/xx not_active IP Right Cessation
- 1992-05-04 DK DK92582A patent/DK58292D0/da not_active Application Discontinuation
1994
- 1994-01-18 BG BG098378A patent/BG60762B2/bg unknown

Also Published As

Publication number	Publication date
FI854335A0 (fi)	1985-11-05
KR930004673B1 (ko)	1993-06-03
NO854671L (no)	1986-05-26
PH22016A (en)	1988-05-13
EP0183492A1 (en)	1986-06-04
SG106891G (en)	1992-02-14
IE852929L (en)	1986-05-23
JPS61143366A (ja)	1986-07-01
ES8801248A1 (es)	1987-12-16
IE58165B1 (en)	1993-07-28
DK58292A (da)	1992-05-04
AU3332989A (en)	1989-08-10
DK164903C (da)	1993-01-25
GB2167408A (en)	1986-05-29
CA1268770C (en)	1990-05-08
HK3592A (en)	1992-01-17
DD258230A1 (de)	1988-07-13
AU586839B2 (en)	1989-07-27
ES549178A0 (es)	1987-04-01
FI854335A (fi)	1986-05-24
HUT38913A (en)	1986-07-28
DK540485D0 (da)	1985-11-22
FI80264B (fi)	1990-01-31
EP0310745A3 (en)	1989-10-11
GB8429578D0 (en)	1985-01-03
GR852817B (da)	1986-03-21
CA1266669A1 (en)	1990-03-13
PT81542A (en)	1985-12-01
DE3574252D1 (en)	1989-12-21
EP0183492B1 (en)	1989-11-15
ZA858942B (en)	1986-08-27
NO166585C (no)	1991-08-21
IL77111A0 (en)	1986-04-29
KR860004028A (ko)	1986-06-16
PT81542B (pt)	1988-03-03
DK164903B (da)	1992-09-07
ATE85050T1 (de)	1993-02-15
ATE47997T1 (de)	1989-12-15
IL77111A (en)	1989-09-28
NZ214258A (en)	1989-02-24
EP0310745B1 (en)	1993-01-27
ES557268A0 (es)	1987-12-16
FI80264C (fi)	1990-05-10
GB2167408B (en)	1988-05-25
ES8704462A1 (es)	1987-04-01
AU5008385A (en)	1986-05-29
DE3587045D1 (de)	1993-03-11
BG60762B2 (bg)	1996-02-29
DK540485A (da)	1986-05-24
NO166585B (no)	1991-05-06
EP0310745A2 (en)	1989-04-12
DE3587045T2 (de)	1993-06-03
SU1424736A3 (ru)	1988-09-15
US4689339A (en)	1987-08-25
JPH064597B2 (ja)	1994-01-19
HU195189B (en)	1988-04-28

Publication	Publication Date	Title
DK58292A (da)	1992-05-04	Som mellemprodukter anvendelige 4(5)-imidazolderivater
PH23739A (en)	1989-11-03	Piperidine derivative and pharmaceutical composition
FI850140L (fi)	1985-07-14	Kemiska foereningar.
FI871655A (fi)	1987-11-16	Foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat.
PT87277A (pt)	1988-05-01	Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same
DE3264556D1 (en)	1985-08-08	Sulfimines, their salts and their preparation, and pharmaceutical compositions containing them
ATE29133T1 (de)	1987-09-15	Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
DE3160719D1 (en)	1983-09-08	Benzothiopyrano(2,3-c) pyridines and their acid addition salts, their preparation, their use as medicaments and compositions containing them
EP0273357A3 (en)	1989-11-02	Fluorine-containing macrolide compounds, pharmaceutical compositions comprising the same and their use for the manufacture of medicaments

Legal Events

Date	Code	Title	Description
1996-07-22	AHB	Application shelved due to non-payment